Clinical Trials

Showing trials with last updates posted in 2020.

NCT02879669 | UNKNOWN | PHASE1/PHASE2
31 participants

A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma

Study Type:
INTERVENTIONAL
Last Updated:
2020-10-08
Start Date:
2016-06-30
Completion:
2020-05-31
Conditions
  • To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page